Preview

Бюллетень сибирской медицины

Расширенный поиск

Менеджмент лекарственной помощи — современная парадигма фармацевтической практики

https://doi.org/10.20538/1682-0363-2012-6-119-125

Полный текст:

Аннотация

В обзоре рассмотрены основные этапы и причины изменения представлений о роли специалиста с фармацевтическим образованием в системе здравоохранения. Представлены ключевые направления реализации концепции менеджмента лекарственной помощи на популяционном и индивидуальном уровне.

Об авторах

Е. В. Каракулова
Сибирский государственный медицинский университет, г. Томск
Россия


Е. Е. Лоскутова
Российский университет дружбы народов, г. Москва


Е. А. Ушкалова
Научный центр акушерства, гинекологии и перинатологии им. акад. В.И. Кулакова, г. Москва


Список литературы

1. Дремова Н.Б., Овод А.И., Коржавых Э.А. Основы фар-мацевтической помощи в здравоохранении. Курск: КГМУ, 2009. 412 с.

2. Макроэкономика и здоровье: инвестиции в здоровье в целях экономического развития. Доклад комиссии по макроэкономике и здоровью. ВОЗ, 2001. 224 с.

3. Стратегия предупреждения хронических заболеваний в Европе. Европейское региональное бюро ВОЗ, 2005. 64 с.

4. Экономические последствия неинфекционных заболева-ний и травм в Российской Федерации / M. Suhrcke, L. Rocco, M. McKee и др. Европейская обсерватория по системам и политике здравоохранения, 2008. 83 с.

5. Adherence to Long-Term Therapies: Evidence for Action. WHO, 2003. 199 p.

6. Almarsdottir A.B., Traulsen J.M. Rational use of medicines — an important issue in pharmaceutical policy // Pharm. World Sсi. 2005. V. 27. P. 76—80.

7. Alvarez-Risco A., van Mil J.W. Pharmaceutical care in com-munity pharmacies: practice and research in Peru // Ann. Pharmacother. 2007. V. 41, № 12. P. 2032—2037.

8. Anderson S. Community pharmacy and public health in Great Britain, 1936 to 2006: how a phoenix rose from the ashes // J. Epidemiol. Community Health. 2007. V. 61, № 10. P. 844—848.

9. Barnett M.J., Frank J., Wehring H. et al. Analysis of phar-macist-provided medication therapy management (MTM) services in community pharmacies over 7 years // J. Manag. Care Pharm. 2009. V. 15, № 1. P. 18—31.

10. Basak S.C., van Mil J.W., Sathyanarayana D. The changing roles of pharmacists in community pharmacies: perception of reality in India // Pharm. World Sci. 2009. V. 31. P. 612—618.

11. Benedict N. Virtual patients and problem-based learning in advanced therapeutics // Am. J. Pharm. Educ. 2010. V. 74, № 8. PMCID: PMC2987283.

12. Berenguer B., La Casa C., de la Matta M.J., Martín-Calero M.J. Pharmaceutical care: past, present and future // Curr. Pharm. Des. 2004. V. 10, № 31. P. 3931—3946.

13. Bluml B.M. Definition of medication therapy management: development of professionwide consensus // J. Am. Pharm. Assoc. 2005. V. 45. № 5. P. 566—572.

14. Bodenheimer T. Disease management in the American mar-ket // BMJ. 2000. V. 320. P. 563—566.

15. Bunting B.A., Smith B.H., Sutherland S.E. The Asheville Project: clinical and economic outcomes of a community-based long-term medication therapy management program for hypertension and dyslipidemia // J. Am. Pharm. Assoc. 2008. V. 48, № 1. P. 23—31.

16. Caring for people with chronic conditions: a health system perspective / ed. E. Nolte, M. McKee. Open University Press: McGraw-Hill. 2008. 259 p.

17. Chisholm-Burns M.A., Kim Lee J., Spivey .CA. et al. US pharmacists' effect as team members on patient care: system-atic review and meta-analyses // Med. Care. 2010. V. 48, № 10. P. 923—933.

18. Cooksey J.A., Knapp K.K., Walton S.M., Cultice J.M. Challenges to the pharmacist profession from escalating pharmaceutical demand // Health Affairs. 2002. V. 21, № 5. P. 182—188.

19. Cordina M., McElnay J.C., Hughes C.M. Assessment of a community pharmacy-based program for patients with asthma // Pharmacother. 2001. V. 21, № 10. P. 1196—1203.

20. Cranor C.W., Bunting B.A., Christensen D.B. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program // J. Am. Pharm. Assoc. 2003. V. 43. P. 173—184.

21. Developing pharmacy practice — A focus on patient care. Working draft for field testing and revision — 2006 edition. WHO. FIP, 2006. 87 p.

22. Emmerton L., Marriott J., Bessell T. et al. Pharmacists and prescribing rights: review of international developments // J. Pharm. Pharmaceut. Sci. 2005. V. 8, № 2. P. 217—225.

23. Fang Y., Yang S., Feng B. et al. Pharmacists' perception of pharmaceutical care in community pharmacy: a questionnaire survey in Northwest China // Health Soc. Care Community. 2011. V. 19, № 2. P. 189—197.

24. FIP statement of policy the role of the pharmacist in the pre-vention and treatment of chronic disease. International Pharmaceutical Federation, 2006. 3 p.

25. FIP statement of professional standards pharmaceutical care. International Pharmaceutical Federation, 1998. 3 p.

26. Fitzner K., Fox K., Schmidt J. et al. Implementation and out-comes of commercial disease management programs in the United States: the disease management outcomes consolida-tion survey // Dis. Manag. 2005. V. 8, № 4. P. 253—264.

27. Fitzpatrick R. Pharmaceutical care or medicines manage-ment? // Hospital Pharmacy Europe. 2006. Issue 27.URL: http://www.hospitalpharmacyeurope.com.

28. George P.P., Molina J.A., Cheah J. et al. The evolving role of the community pharmacist in chronic disease management — a literature review// Ann. Acad. Med. Singapore. 2010. V. 39, № 11. P. 861—867.

29. Hepler C.D., Strand L.M. Opportunities and responsibilities in pharmaceutical care // Am. J. Hosp. Pharm. 1990. V. 47. P. 533—543.

30. Hepler C.D., Strand L.M., Tromp D., Sakolchai S. Criti-cally examining pharmaceutical care // J. Am. Pharm. Assoc. (Wash). 2002. V. 42, № 5. P. 18—19.

31. Herrier R.N. Pharmacist-based chronic disease management-why is it taking so long? // US Pharm. Rev. 2006. URL: http://www.touchbriefings.com/pdf/1895/Herrier_edit.qxp.pdf

32. Holloway K., van Dijk L. The world medicines situation 2011. Rational use of medicines. WHO, 2011. 24 p.

33. Innovative care for chronic conditions: building blocks for actions: global report. WHO, 2002. 112 p.

34. Isetts B.J., Brown L.M., Schodelmeyer S.W., Lenarz L.A. Quality assessment of a collaborative approach for decreasing drug-related morbidity and achieving therapeutic goals // Arch. Intern. Med. 2003. V. 163. P. 1813—1820.

35. Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for Quality of Pharmacy Services. WHO Technical Report Series, No. 961, 2011, Annex 8. 14 p.

36. Jones E.J., Mackinnon N.J., Tsuyuki R.T. Pharmaceutical care in community pharmacies: practice and research in Canada // Ann. Pharmacother. 2005. V. 39, № 9. P. 1527—33.

37. Ketner L. Population management takes disease management to the next level // Healthc.Financ. Manag. 1999. V. 53. № 8. P. 36—39.

38. Knapp K.K., Okamoto M.P., Black B.L. ASHP survey of ambulatory care pharmacy practice in health systems: 2004 // Am. J. Health Syst. Pharm. 2004. V. 62. P. 274—284.

39. Kuhn C., Powell P.H., Sterrett J.J. Elective course on medi-cation therapy management services // Am. J. Pharm. Educ. 2010. V. 74, № 3. PMCID: PMC2865406.

40. Levy R.A., Cocks D. Component management fails to save health care system costs. National Pharmaceutical Council, 1999. 81 р.

41. McAuley J.W., Miller M.A., Klatte E., Shneker B.F. Pa-tients with epilepsy's perception on community pharmacist's current and potential role in their care // Epilepsy Behav. 2009. V. 14, № 1. P. 141—145.

42. McGivney M.S., Meyer S.M., Duncan-Hewitt W. et al. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care // J. Am. Pharm. Assoc. 2007. V. 47. P. 620—628.

43. Mikeal R.L., Brown T.R., Lazarus H.L., Vinson M.C.Quality of pharmaceutical care in hospitals // American Journal of Health—System Pharmacy. 1975. V. 32, № 6. P. 567—574.

44. Nace D.K., Grundy P., Nielsen M. Integrating comprehen-sive medication management to optimize patient outcomes. Second edition. 2012. 25 p.

45. Niskanen J.J. Finnish care integrated? // Int. J. Integr. Care. 2002; V. 2: e16.

46. Nkansah N., Mostovetsky O., Yu C. et al. Effect of outpa-tient pharmacists' non-dispensing roles on patient outcomes and prescribing patterns // Cochrane Database Syst. Rev. 2010. V. 7. CD000336.

47. Package of essential noncommunicable (PEN) disease inter-ventions for primary health care in low-resource settings. WHO, 2010. 65 p.

48. Pharmacy education taskforce action plan 2008—2010. FIP. UNESCO. WHO. 2008. 6 p.

49. Promoting rational use of medicines: core components — WHO policy perspectives on medicines, No. 005, September 2002. URL: http://apps.who.int/medicinedocs/en/d/Jh3011e/.

50. Rodriguez de Bittner M., Adams A.J., Burns A.L. et al. Re-port of the 2010—2011 professional affairs committee: ef-fective partnerships to implement pharmacists’ services in team-based, patient-centered healthcare // Am. J. Pharm. Educ. 2011. V. 75, № 10. PMCID: PMC327901.

51. Schumock G.T., Butler M.G., Meek P.D. et al. Evidence of the economic benefit of clinical pharmacy services: 1996—2000 // Pharmacother. 2003. V. 23. P. 113—132.

52. Strand L.M., Cipolle R.J., Morley P.C., Frakes M.J. The impact of pharmaceutical care practice on the practitioner and the patient in the ambulatory practice setting: twenty-five years of experience // Current Pharmaceutical Design. 2004. V. 10. P. 3987—4001.

53. The Boston Consulting Group on Strategy: Classic concepts and new perspectives / edit. C.W. Stern, M.S. Deimler. Ho-boken, New Jersey: Wiley, 2006. 414 p.

54. The Rational Use of Drugs — Report of the Conference of Experts, Nairobi 25—29 November 1985. WHO, 1987. 338 p.

55. The role of the pharmacist in the health care system. WHO. 1994. 60 p.

56. Traulsen J.M., Almarsdóttir A.B. Pharmaceutical policy and the pharmacy profession // Pharm. World Sci. 2005. V. 27, № 5. P.359—63.

57. Volmer D., Vendla K., Vetka A. et al. Pharmaceutical care in community pharmacies: practice and research in Estonia // Ann. Pharmacother. 2008. V. 42, № 7. P. 1104—1111.

58. Welch W.P., Bergsten C., Cutler C. et al. Disease manage-ment practices of health plans // Am. J. Manag. Care. 2002. V. 8, № 4. P. 353—361.

59. WhitmarshS., Futter B., Rouse M. et al. A Case Study in Terminology: the FIP Pharmacy Education Taskforce // Am. J. Pharm. Educ. 2010. V. 74, № 7. PMCID: PMC2972529.

60. Zellmer W.A. The future of health-system pharmacy: oppor-tunities and challenges in practice model change // Ann. Pharmacother. 2012. V. 46, № 4. P. 41—45.


Для цитирования:


Каракулова Е.В., Лоскутова Е.Е., Ушкалова Е.А. Менеджмент лекарственной помощи — современная парадигма фармацевтической практики. Бюллетень сибирской медицины. 2012;11(6):119-125. https://doi.org/10.20538/1682-0363-2012-6-119-125

For citation:


Karakulova Y.V., Loskutova Y.Y., Ushkalova Y.A. Medicines management — modern paradigm for pharmacy practice. Bulletin of Siberian Medicine. 2012;11(6):119-125. (In Russ.) https://doi.org/10.20538/1682-0363-2012-6-119-125

Просмотров: 111


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1682-0363 (Print)
ISSN 1819-3684 (Online)